These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 10990520

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Gender difference in the interaction of smoking and monoamine oxidase B intron 13 genotype in Parkinson's disease.
    Kelada SN, Costa-Mallen P, Costa LG, Smith-Weller T, Franklin GM, Swanson PD, Longstreth WT, Checkoway H.
    Neurotoxicology; 2002 Oct; 23(4-5):515-9. PubMed ID: 12428723
    [Abstract] [Full Text] [Related]

  • 4. The EcoRV genetic polymorphism of human monoamine oxidase type A is not associated with Parkinson's disease and does not modify the effect of smoking on Parkinson's disease.
    Costa-Mallen P, Checkoway H, Fishel M, Cohen AW, Smith-Weller T, Franklin GM, Swanson PD, Costa LG.
    Neurosci Lett; 2000 Jan 07; 278(1-2):33-6. PubMed ID: 10643794
    [Abstract] [Full Text] [Related]

  • 5. The dopamine D2 receptor gene is a susceptibility locus for Parkinson's disease.
    Oliveri RL, Annesi G, Zappia M, Civitelli D, De Marco EV, Pasqua AA, Annesi F, Spadafora P, Gambardella A, Nicoletti G, Branca D, Caracciolo M, Aguglia U, Quattrone A.
    Mov Disord; 2000 Jan 07; 15(1):127-31. PubMed ID: 10634251
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A genetic polymorphism of MAO-B modifies the association of cigarette smoking and Parkinson's disease.
    Checkoway H, Franklin GM, Costa-Mallen P, Smith-Weller T, Dilley J, Swanson PD, Costa LG.
    Neurology; 1998 May 07; 50(5):1458-61. PubMed ID: 9596006
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Possible interaction between MAOA and DRD2 genes associated with antisocial alcoholism among Han Chinese men in Taiwan.
    Wang TJ, Huang SY, Lin WW, Lo HY, Wu PL, Wang YS, Wu YS, Ko HC, Shih JC, Lu RB.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan 30; 31(1):108-14. PubMed ID: 17007976
    [Abstract] [Full Text] [Related]

  • 10. Effects of Interaction Between Dopamine D2 Receptor and Monoamine Oxidase A Genes on Smoking Status in Young Men.
    Huang CL, Ou WC, Chen PL, Liu CN, Chen MC, Lu CC, Chen YC, Lin MH, Huang CS.
    Biol Res Nurs; 2015 Jul 30; 17(4):422-8. PubMed ID: 26015071
    [Abstract] [Full Text] [Related]

  • 11. The DRD2 TaqIA polymorphism and demand of dopaminergic medication in Parkinson's disease.
    Paus S, Grünewald A, Klein C, Knapp M, Zimprich A, Janetzky B, Möller JC, Klockgether T, Wüllner U.
    Mov Disord; 2008 Mar 15; 23(4):599-602. PubMed ID: 18175338
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Impact of COMT H108L, MAOB int 13 A>G and DRD2 haplotype on the susceptibility to Parkinson's disease in South Indian subjects.
    Kumudini N, Umai A, Devi YP, Naushad SM, Mridula R, Borgohain R, Kutala VK.
    Indian J Biochem Biophys; 2013 Oct 15; 50(5):436-41. PubMed ID: 24772965
    [Abstract] [Full Text] [Related]

  • 14. Monoamine oxidase B polymorphism, cigarette smoking and risk of Parkinson's disease: a study in an Asian population.
    Tan EK, Chai A, Lum SY, Shen H, Tan C, Teoh ML, Yih Y, Wong MC, Zhao Y.
    Am J Med Genet B Neuropsychiatr Genet; 2003 Jul 01; 120B(1):58-62. PubMed ID: 12815741
    [Abstract] [Full Text] [Related]

  • 15. Dopamine D2 receptor TaqIA and TaqIB polymorphisms in Parkinson's disease.
    Tan EK, Tan Y, Chai A, Tan C, Shen H, Lum SY, Fook-Cheong SM, Teoh ML, Yih Y, Wong MC, Zhao Y.
    Mov Disord; 2003 May 01; 18(5):593-5. PubMed ID: 12722176
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium.
    McGuire V, Van Den Eeden SK, Tanner CM, Kamel F, Umbach DM, Marder K, Mayeux R, Ritz B, Ross GW, Petrovitch H, Topol B, Popat RA, Costello S, Manthripragada AD, Southwick A, Myers RM, Nelson LM.
    J Neurol Sci; 2011 Aug 15; 307(1-2):22-9. PubMed ID: 21663922
    [Abstract] [Full Text] [Related]

  • 18. Dopamine D2 receptor gene variants and response to rasagiline in early Parkinson's disease: a pharmacogenetic study.
    Masellis M, Collinson S, Freeman N, Tampakeras M, Levy J, Tchelet A, Eyal E, Berkovich E, Eliaz RE, Abler V, Grossman I, Fitzer-Attas C, Tiwari A, Hayden MR, Kennedy JL, Lang AE, Knight J, ADAGIO investigators.
    Brain; 2016 Jul 15; 139(Pt 7):2050-62. PubMed ID: 27190009
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.